home / stock / wint / wint news


WINT News and Press, Windtree Therapeutics Inc. From 10/19/21

Stock Information

Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com

Menu

WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...

WINT - AlloVir, InflaRx leads healthcare gainers; Galera Therapeutics, Atea Pharmaceuticals among major losers

Gainers: AlloVir (NASDAQ:ALVR) +14%, InflaRx (NASDAQ:IFRX) +14%, Harmony Biosciences (NASDAQ:HRMY) +13%, Omeros (NASDAQ:OMER) +11%, Prelude Therapeutics (NASDAQ:PRLD) +11%. Losers: Galera Therapeutics (NASDAQ:GRTX) -68%, Atea Pharmaceutic...

WINT - Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock

WARRINGTON, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that on Tuesday, October 19, 2...

WINT - Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study

WARRINGTON, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the results of a US physician ...

WINT - Windtree to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

WARRINGTON, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President ...

WINT - SCWorx, Liminal BioSciences leads healthcare gainers; Axsome Therapeutics, BioVie among major losers

Gainers: SCWorx (NASDAQ:WORX) +32%, Liminal BioSciences (NASDAQ:LMNL) +28%, Allied Healthcare Products (NASDAQ:AHPI) +20%, Windtree Therapeutics (NASDAQ:WINT) +17%, NRx Pharmaceuticals (NASDAQ:NRXP) +15%. Losers: Axsome Therapeutics (NASDAQ:AXSM) -42%,&...

WINT - NVTA, SOS and HVBT among pre market gainers

Golden Nugget Online Gaming (NASDAQ:GNOG) +48% DraftKings acquires Golden Nugget Online Gaming in an all-stock deal valued at $1.56B BIT Mining (NYSE:BTCM) +33%. Windtree Therapeutics (NASDAQ:WINT) +33%. Select Interior Concepts (NASDAQ:SIC) +30% an affiliate of Sun Capita...

WINT - Windtree TherapeuticS EPS misses by $0.94

Windtree TherapeuticS (NASDAQ:WINT): Q2 GAAP EPS of -$1.42 misses by $0.94. Cash and cash equivalents of $30M Press Release For further details see: Windtree TherapeuticS EPS misses by $0.94

WINT - Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the secon...

WINT - Windtree Appoints Randall White, Ph.D., as Vice President, Clinical Program Management

WARRINGTON, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointment of Randall Whi...

WINT - Windtree to Present at Access to Giving Virtual Investor Conference

WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President a...

Previous 10 Next 10